Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eden vs You + Me (He & She MD)

By GLP-1 ScorecardUpdated

Eden
Site position #16

Higher score

You + MeFactor scores not reassessed.
Site position #100

Lower score

Score comparison

Eden has the higher recorded score — 81.6/100 to 71.5/100.

Eden grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.

Before you choose

You + Me (He & She MD) does not publish a semaglutide price, so its You + Me (He & She MD) review sets out what it does disclose, while the Eden review explains the conditions attached to Eden's figure. The semaglutide cost page compares published rates across the field. Ask You + Me (He & She MD) for a written total before treating either one as the cheaper choice.

If neither one fits, Eden vs HeliMeds and Effecty vs You + Me (He & She MD) compare each of them with another graded program, and the list of alternatives to Eden ranks the programs closest to Eden on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueEden +31
85
54
Dose & formulationYou + Me (He & She MD) +2
86
88
Clinical oversightYou + Me (He & She MD) +29
55
84
Labs & monitoringEden +30
92
62
FulfillmentEden +1
93
92
Contract termsEden +49
90
41
Eden · top barYou + Me (He & She MD) · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEdenYou + Me (He & She MD)
WeighScore81.6/10071.5/100
GradeB−C
Site position#16#100
SemaglutideAdvertised $99/mo bundle; linked membership terms conflict—confirm checkoutConflicting promotional terms
TirzepatideAdvertised $129/mo bundle; linked membership terms conflict—confirm checkout$159/mo (advertised promotion, selected quote required)
CoverageAll 50 statesConfirm treatment availability by state
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Eden

Site position #16 · B−

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Strengths

  • Current compounded offer includes medication and support
  • Homepage also advertises branded prescription pathways; eligibility and cost require confirmation
  • Named pharmacy operation and partner network can be investigated

What to consider

  • Linked membership terms describe a separate fee model
  • Landing-page warranty and terms use different thresholds and conditions
  • FDA warning history remains relevant; a new offer does not establish resolution
You + Me (He & She MD)

Site position #100 · C

Factor scores not reassessed.

Strengths

  • Describes clinician access, coaching and progress tracking.
  • Publishes a plan-specific cancellation FAQ.

What to consider

  • Confirm which promotion and renewal apply to the selected term.
  • The FAQ describes prepaid plans as generally nonrefundable after approval and payment.

Featured provider

Eden

Eden scores 81.6/100 (B−). Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.

Commercial relationships affect this placement. The score comparison above is separate.

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard